← Back to guidelines
Cardiology113 papers

Brain stem infarction

Last edited: 4/16/2026

Overview

Brain stem infarction involves damage to critical structures within the brain stem, often leading to severe neurological deficits and potentially brain stem death due to disruption of vital autonomic functions 1.

Diagnosis

  • Serial assessment using Sequential Organ Failure Assessment (SOFA) scores to monitor progression of organ dysfunction 1.
  • Clinical criteria for brain stem death typically include apnea, absence of brain stem reflexes, and dilated pupils unresponsive to light 1.
  • Management

  • Supportive care focusing on maintaining ventilation and circulatory stability 1.
  • No specific pharmacological treatments mentioned for reversing brain stem infarction directly 1.
  • Special Populations

  • No specific data provided regarding management differences in pregnancy, pediatrics, elderly, or those with comorbidities 1.
  • Key Recommendations

  • Monitor organ dysfunction closely using SOFA scores to guide timing of organ donation discussions post brain stem death declaration (Evidence: Moderate) 1.
  • Implement immediate supportive measures for ventilation and circulation in patients with suspected brain stem infarction (Evidence: Expert opinion) 1.
  • Consider the rapid progression timeline; median time from ICU admission to brain stem death declaration is approximately 18.8 hours, impacting organ retrieval planning (Evidence: Moderate) 1.
  • References

    1 Lytle FT, Afessa B, Keegan MT. Progression of organ failure in patients approaching brain stem death. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009. link

    Original source

    1. [1]
      Progression of organ failure in patients approaching brain stem death.Lytle FT, Afessa B, Keegan MT American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2009)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG